Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6538750rdf:typepubmed:Citationlld:pubmed
pubmed-article:6538750lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:6538750lifeskim:mentionsumls-concept:C0599918lld:lifeskim
pubmed-article:6538750pubmed:issue4lld:pubmed
pubmed-article:6538750pubmed:dateCreated1984-5-10lld:pubmed
pubmed-article:6538750pubmed:abstractTextCisplatin nephrotoxicity was evaluated by serial pretreatment and post-treatment 24-hour creatinine clearance determinations in 43 patients who received 295 monthly infusions of 60 mg/m2 of this drug. An aggressive standard hydration protocol was used without diuretic administration. Fourteen of these patients had a single kidney. Older patients and patients with a single kidney had lower pretreatment creatinine clearances when compared with younger persons with two functioning kidneys. Older and younger patients with two kidneys had an equal, progressive, dose-related deterioration of renal function. Renal function did not decline in persons with a single kidney but did so markedly in those with two kidneys. When administered at 60 mg/m2, cisplatin dose or schedule modification is not indicated on the basis of advancing age or decreased renal function secondary to the surgical loss or total ureteral obstruction of one kidney.lld:pubmed
pubmed-article:6538750pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6538750pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6538750pubmed:languageenglld:pubmed
pubmed-article:6538750pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6538750pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6538750pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6538750pubmed:statusMEDLINElld:pubmed
pubmed-article:6538750pubmed:monthAprlld:pubmed
pubmed-article:6538750pubmed:issn0002-9343lld:pubmed
pubmed-article:6538750pubmed:authorpubmed-author:ShimaHHlld:pubmed
pubmed-article:6538750pubmed:authorpubmed-author:KennedyB JBJlld:pubmed
pubmed-article:6538750pubmed:authorpubmed-author:HrusheskyW...lld:pubmed
pubmed-article:6538750pubmed:issnTypePrintlld:pubmed
pubmed-article:6538750pubmed:volume76lld:pubmed
pubmed-article:6538750pubmed:ownerNLMlld:pubmed
pubmed-article:6538750pubmed:authorsCompleteYlld:pubmed
pubmed-article:6538750pubmed:pagination579-84lld:pubmed
pubmed-article:6538750pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:meshHeadingpubmed-meshheading:6538750-...lld:pubmed
pubmed-article:6538750pubmed:year1984lld:pubmed
pubmed-article:6538750pubmed:articleTitleLack of age-dependent cisplatin nephrotoxicity.lld:pubmed
pubmed-article:6538750pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6538750pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6538750pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6538750lld:pubmed